Pfizer (Australia) METHOTREXATE 50mg/2mL

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024

SITAGLIPTIN LUPIN sitagliptin (as hydrochloride monohydrate) 25 mg

Availability: Unavailable Deletion from market: 14 Jun 2024

SITAGLIPTIN LUPIN sitagliptin (as hydrochloride monohydrate) 50 mg

Availability: Unavailable Deletion from market: 14 Jun 2024

SITAGLIPTIN LUPIN sitagliptin (as hydrochloride monohydrate) 100 mg

Availability: Unavailable Deletion from market: 14 Jun 2024

ZEJULA niraparib (as tosilate monohydrate) 100 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Jan 2025

METHYLPHENIDATE XR ARX methylphenidate hydrochloride 36 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Jul 2024

METHYLPHENIDATE XR ARX methylphenidate hydrochloride 27 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Jul 2024

METHYLPHENIDATE XR ARX methylphenidate hydrochloride18 mg modified release tablet bottle

Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Jun 2024

METHOBLASTIN methotrexate 10mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Nov 2024

DILTIAZEM SANDOZ CD diltiazem hydrochloride 180mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 11 Jun 2024

DILTIAZEM SANDOZ CD diltiazem hydrochloride 240mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 11 Jun 2024

DILTIAZEM SANDOZ CD diltiazem hydrochloride 360mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 11 Jun 2024